During the past decade, Ishikawa Prefectural Central Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ishikawa Prefectural Central Hospital" #1 sponsor was "Bayer" with 3 trials, followed by "Japan Clinical Cancer Research Organization" with 3 trials sponsored, "Kyowa Kirin Co., Ltd." with 3 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ishikawa Prefectural Central Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator, "Japan Blood Products Organization" with 1 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Ishikawa Prefectural Central Hospital" are "Gastric Cancer" (4 trials), "Coronary Artery Disease" (2 trials), "Acute Myocardial Infarction" (1 trials), "Angina Pectoris" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Ishikawa Prefectural Central Hospital" in a lesser frequency.

Most popular intervention types in "Ishikawa Prefectural Central Hospital" are "Drug" (18 trials), "Device" (3 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "S-1" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "Abemaciclib" (1 trials) and "Antithrombin gamma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ishikawa Prefectural Central Hospital" are 20 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ishikawa Prefectural Central Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ishikawa Prefectural Central Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ishikawa Prefectural Central Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".